Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,904 | 186 | 96.5% |
| Education | $104.95 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $356.92 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.93 | 17 | $0 (2024) |
| PFIZER INC. | $305.29 | 43 | $0 (2021) |
| Exact Sciences Corporation | $250.18 | 8 | $0 (2024) |
| Allergan, Inc. | $216.58 | 9 | $0 (2020) |
| Novo Nordisk Inc | $214.03 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $194.75 | 6 | $0 (2024) |
| Lilly USA, LLC | $133.55 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $130.10 | 17 | $0 (2019) |
| Amgen Inc. | $109.42 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.07 | 19 | Bayer Healthcare Pharmaceuticals Inc. ($205.39) |
| 2023 | $382.42 | 19 | Exact Sciences Corporation ($148.78) |
| 2022 | $186.67 | 11 | AstraZeneca Pharmaceuticals LP ($81.02) |
| 2021 | $318.97 | 14 | Astellas Pharma US Inc ($99.95) |
| 2020 | $400.80 | 23 | Novo Nordisk Inc ($136.91) |
| 2019 | $160.31 | 10 | Radius Health, Inc. ($48.89) |
| 2018 | $177.06 | 13 | GlaxoSmithKline, LLC. ($30.25) |
| 2017 | $910.60 | 79 | Allergan Inc. ($187.84) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 2 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $45.75 | General |
| Category: Oncology | ||||||
| 09/28/2023 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: GERD | ||||||
| 09/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Oncology | ||||||
| 07/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Oncology | ||||||
| 07/17/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Insulin Pump | ||||||
| 07/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardio-renal | ||||||
| 06/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: Oncology | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: INSOMNIA | ||||||
| 05/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardio-renal | ||||||
| 03/28/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Urology | ||||||
| 01/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardio-renal | ||||||
| 10/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardio-renal | ||||||
| 09/25/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.95 | General |
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Respiratory | ||||||
| 05/31/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.78 | General |
| 05/03/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiovascular | ||||||
| 05/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 04/19/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/28/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.89 | General |
| 02/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Cardio-renal | ||||||
| 01/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardio-renal | ||||||
| 11/02/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,145 | 4,144 | $432,954 | $197,551 |
| 2022 | 23 | 1,299 | 4,317 | $458,954 | $219,831 |
| 2021 | 22 | 2,107 | 4,550 | $396,518 | $165,930 |
| 2020 | 21 | 1,738 | 6,182 | $576,498 | $229,704 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2021 | 37 | 293 | $24,768 | $9,202 | 37.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 51 | $9,986 | $6,961 | 69.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $6,417 | $5,134 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 33 | $3,757 | $2,172 | 57.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $7,158 | $2,076 | 29.0% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 32 | 33 | $6,282 | $1,983 | 31.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $4,592 | $1,611 | 35.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 43 | 43 | $1,459 | $792.06 | 54.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 43 | 43 | $1,459 | $792.06 | 54.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 50 | $2,060 | $561.50 | 27.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 37 | 42 | $1,800 | $422.64 | 23.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2021 | 26 | 26 | $905.60 | $384.02 | 42.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 12 | 12 | $698.50 | $279.72 | 40.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 15 | 64 | $512.00 | $62.76 | 12.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 15 | 128 | $192.00 | $15.26 | 7.9% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 343 | 2,932 | $249,220 | $88,115 | 35.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2020 | 119 | 810 | $72,900 | $38,047 | 52.2% |
| 99487 | Complex chronic care management services 60 minutes clinical staff time | Office | 2020 | 335 | 621 | $111,780 | $37,641 | 33.7% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2020 | 48 | 445 | $33,375 | $17,478 | 52.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 217 | $35,805 | $16,852 | 47.1% |
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2020 | 42 | 217 | $17,360 | $7,144 | 41.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 75 | $14,025 | $7,088 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $6,510 | $4,837 | 74.3% |
| 93922 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 42 | 43 | $7,740 | $2,367 | 30.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 37 | $3,938 | $1,781 | 45.2% |
About Dr. Dawn Walker, DO
Dr. Dawn Walker, DO is a Family Medicine healthcare provider based in Willcox, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306895529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Walker, DO has received a total of $3,009 in payments from pharmaceutical and medical device companies, with $472.07 received in 2024. These payments were reported across 188 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,904).
As a Medicare-enrolled provider, Walker has provided services to 6,289 Medicare beneficiaries, totaling 19,193 services with total Medicare billing of $813,015. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Willcox, AZ
- Active Since 05/06/2006
- Last Updated 05/20/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306895529
Products in Payments
- Kerendia (Drug) $356.92
- Cologuard Collection Kit (Device) $250.18
- FARXIGA (Drug) $127.63
- VIBERZI (Drug) $125.23
- FLECTOR (Drug) $114.65
- Ozempic (Drug) $90.84
- RYBELSUS (Drug) $87.83
- BEVESPI AEROSPHERE (Drug) $86.35
- Tymlos (Biological) $76.51
- XARELTO (Drug) $71.67
- JARDIANCE (Drug) $65.92
- TRULICITY (Drug) $63.07
- VRAYLAR (Drug) $59.55
- INVOKANA (Drug) $58.43
- LYRICA (Drug) $57.87
- EMGALITY (Drug) $47.40
- Myrbetriq (Drug) $43.67
- COLOGUARD DNA CAPTURE REAGENTS (Device) $41.09
- Vascepa (Drug) $40.77
- Repatha (Biological) $40.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.